These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2558539

  • 21. Deoxycytidine kinase and cytosine nucleoside deaminase activities in synchronized cultures of normal rat kidney cells.
    Wan CW, Mak TW.
    Cancer Res; 1978 Sep; 38(9):2768-72. PubMed ID: 679182
    [Abstract] [Full Text] [Related]

  • 22. Induction of resistance to 1-beta-D-arabinofuranosylcytosine in human H9 cell line by simian immunodeficiency virus.
    Yusa K, Oh-hara T, Tsuruo T.
    Biochem Biophys Res Commun; 1995 Jan 17; 206(2):486-91. PubMed ID: 7826366
    [Abstract] [Full Text] [Related]

  • 23. Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell lines.
    Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Peters GJ.
    Adv Exp Med Biol; 1994 Jan 17; 370():139-43. PubMed ID: 7660877
    [No Abstract] [Full Text] [Related]

  • 24. Deamination rates of 1-beta-D-arabinofuranosylcytosine, deoxycytidine and 5-methyl-2'-deoxycytidine in seven hematopoietic cell lines.
    Jekunen A.
    Med Biol; 1987 Jan 17; 65(4):203-8. PubMed ID: 3437781
    [Abstract] [Full Text] [Related]

  • 25. Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase.
    Bouffard DY, Laliberté J, Momparler RL.
    Biochem Pharmacol; 1993 May 05; 45(9):1857-61. PubMed ID: 8494545
    [Abstract] [Full Text] [Related]

  • 26. Role of deoxycytidine kinase (dCK), thymidine kinase 2 (TK2), and deoxycytidine deaminase (dCDA) in the antitumor activity of gemcitabine (dFdC).
    Kroep JR, van Moorsel CJ, Veerman G, Voorn DA, Schultz RM, Worzalla JF, Tanzer LR, Merriman RL, Pinedo HM, Peters GJ.
    Adv Exp Med Biol; 1998 May 05; 431():657-60. PubMed ID: 9598147
    [No Abstract] [Full Text] [Related]

  • 27. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
    Voytek P, Beisler JA, Abbasi MM, Wolpert-DeFilippes MK.
    Cancer Res; 1977 Jul 05; 37(7 Pt 1):1956-61. PubMed ID: 67884
    [Abstract] [Full Text] [Related]

  • 28. Influence of tetrahydrouridine on the phosphorylation of 1-beta-D-arabinofuranosyl-cytosine (ara-C) by enzymes from solid tumors in vitro.
    Furner RL, Mellett LB, Herren TC.
    J Pharmacol Exp Ther; 1975 Jul 05; 194(1):103-10. PubMed ID: 1057009
    [Abstract] [Full Text] [Related]

  • 29. Low cytidine deaminase levels in human hematopoietic cell lines.
    Nygaard P, Sundström C.
    Leuk Res; 1987 Jul 05; 11(8):681-5. PubMed ID: 3626611
    [Abstract] [Full Text] [Related]

  • 30. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.
    Eliopoulos N, Cournoyer D, Momparler RL.
    Cancer Chemother Pharmacol; 1998 Jul 05; 42(5):373-8. PubMed ID: 9771951
    [Abstract] [Full Text] [Related]

  • 31. Characteristics of cytidine aminohydrolase activity in Trypanosoma cruzi and Crithidia fasciculata.
    Kidder GW.
    J Protozool; 1984 May 05; 31(2):298-300. PubMed ID: 6381719
    [Abstract] [Full Text] [Related]

  • 32. Effect of cell growth and cell differentiation on 1-beta-D-arabinofuranosylcytosine metabolism in myeloid cells.
    Chiba P, Tihan T, Eher R, Köller U, Wallner C, Göbl R, Linkesch W.
    Br J Haematol; 1989 Apr 05; 71(4):451-5. PubMed ID: 2713269
    [Abstract] [Full Text] [Related]

  • 33. Changes in the activities of cytidine deaminase during differentiation of HL60 cells induced by 1,25 dihydroxy D3.
    Mejer J, Mortensen BT.
    Leuk Res; 1988 Apr 05; 12(5):405-9. PubMed ID: 3164086
    [Abstract] [Full Text] [Related]

  • 34. On the role of cytidine deaminase in cellular metabolism.
    Nygaard P.
    Adv Exp Med Biol; 1986 Apr 05; 195 Pt B():415-20. PubMed ID: 3532704
    [No Abstract] [Full Text] [Related]

  • 35. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
    Kanno S, Hiura T, Ohtake T, Koiwai K, Suzuki H, Ujibe M, Ishikawa M.
    Clin Chim Acta; 2007 Feb 05; 377(1-2):144-9. PubMed ID: 17097625
    [Abstract] [Full Text] [Related]

  • 36. Identification of cytidine deaminase as inhibitor of granulocyte-macrophage colony formation.
    Bøyum A, Løvhaug D, Seeberg E, Nordlie EM.
    Exp Hematol; 1994 Feb 05; 22(2):208-14. PubMed ID: 7507861
    [Abstract] [Full Text] [Related]

  • 37. Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside.
    Chabot GG, Bouchard J, Momparler RL.
    Biochem Pharmacol; 1983 Apr 01; 32(7):1327-8. PubMed ID: 6189497
    [No Abstract] [Full Text] [Related]

  • 38. Combinations of tetrahydrouridine and cytosine arabinoside in mouse tumors.
    Kreis W, Hession C, Soricelli A, Scully K.
    Cancer Treat Rep; 1977 Oct 01; 61(7):1355-64. PubMed ID: 589601
    [Abstract] [Full Text] [Related]

  • 39. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
    Momparler RL, Eliopoulos N, Bovenzi V, Létourneau S, Greenbaum M, Cournoyer D.
    Cancer Gene Ther; 1996 Oct 01; 3(5):331-8. PubMed ID: 8894252
    [Abstract] [Full Text] [Related]

  • 40. On the interaction of 3,4,5,6-tetrahydrouridine with human liver cytidine deaminase.
    Wentworth DF, Wolfenden R.
    Biochemistry; 1975 Nov 18; 14(23):5099-105. PubMed ID: 53069
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.